Next Article in Journal
Plasma Lipoprotein-Associated Phospholipase A2 Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients
Next Article in Special Issue
Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats
Previous Article in Journal
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
Open AccessReview

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies

1
Molecular Oncology, Biodonostia Research Institute, 20014 San Sebastián, Spain
2
IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain
3
Hematology Department, Donostia Hospital, 20014 San Sebastián, Spain
4
Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford OX3 9DU, UK
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Joint senior authors.
Academic Editor: William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(5), 627; https://doi.org/10.3390/ijms17050627
Received: 13 February 2016 / Revised: 18 April 2016 / Accepted: 18 April 2016 / Published: 27 April 2016
(This article belongs to the Special Issue Liquid Biopsy for Clinical Application)
The effective and efficient management of cancer patients relies upon early diagnosis and/or the monitoring of treatment, something that is often difficult to achieve using standard tissue biopsy techniques. Biological fluids such as blood hold great possibilities as a source of non-invasive cancer biomarkers that can act as surrogate markers to biopsy-based sampling. The non-invasive nature of these “liquid biopsies” ultimately means that cancer detection may be earlier and that the ability to monitor disease progression and/or treatment response represents a paradigm shift in the treatment of cancer patients. Below, we review one of the most promising classes of circulating cancer biomarkers: microRNAs (miRNAs). In particular, we will consider their history, the controversy surrounding their origin and biology, and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice. View Full-Text
Keywords: miRNAs; cfmiRNAs; liquid biopsies miRNAs; cfmiRNAs; liquid biopsies
Show Figures

Graphical abstract

MDPI and ACS Style

Larrea, E.; Sole, C.; Manterola, L.; Goicoechea, I.; Armesto, M.; Arestin, M.; Caffarel, M.M.; Araujo, A.M.; Araiz, M.; Fernandez-Mercado, M.; Lawrie, C.H. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int. J. Mol. Sci. 2016, 17, 627. https://doi.org/10.3390/ijms17050627

AMA Style

Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, Caffarel MM, Araujo AM, Araiz M, Fernandez-Mercado M, Lawrie CH. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. International Journal of Molecular Sciences. 2016; 17(5):627. https://doi.org/10.3390/ijms17050627

Chicago/Turabian Style

Larrea, Erika; Sole, Carla; Manterola, Lorea; Goicoechea, Ibai; Armesto, María; Arestin, María; Caffarel, María M.; Araujo, Angela M.; Araiz, María; Fernandez-Mercado, Marta; Lawrie, Charles H. 2016. "New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies" Int. J. Mol. Sci. 17, no. 5: 627. https://doi.org/10.3390/ijms17050627

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop